Beijing Lingrui Weiye Technology

Beijing Lingrui Weiye Technology is a specialized pharmaceutical research and development company that serves as the core innovation hub for Henan Lingrui Pharmaceutical. Based in Beijing, the company focuses on the development of advanced transdermal drug delivery systems (TDDS), including patches and cataplasms for pain management and neurological conditions. Their product portfolio features high-tech formulations such as fentanyl patches for chronic pain and flurbiprofen cataplasms for musculoskeletal disorders. Lingrui Weiye leverages proprietary adhesive and skin-permeation technologies to enhance drug delivery efficiency and patient compliance. The company's expertise spans the entire development lifecycle, from formulation and process optimization to clinical research and regulatory submission. As a key subsidiary, it plays a vital role in maintaining the parent group's leadership in the Chinese topical patch market.